Woodstock Corp Bicycle Therapeutics PLC Transaction History
Woodstock Corp
- $1.08 Billion
- Q2 2025
A detailed history of Woodstock Corp transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Woodstock Corp holds 23,927 shares of BCYC stock, worth $172,752. This represents 0.02% of its overall portfolio holdings.
Number of Shares
23,927
Previous 24,981
4.22%
Holding current value
$172,752
Previous $224,000
25.89%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding BCYC
# of Institutions
98Shares Held
43.6MCall Options Held
15.6KPut Options Held
27.7K-
Baker Bros. Advisors LP New York, NY10.9MShares$78.6 Million1.1% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.69MShares$26.7 Million0.08% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$24.9 Million7.08% of portfolio
-
Armistice Capital, LLC New York, NY2.67MShares$19.3 Million0.35% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.66MShares$19.2 Million0.12% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $214M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...